KMID : 0387420210320030235
|
|
Korean Society of Oriental Neuropsychiatry 2021 Volume.32 No. 3 p.235 ~ p.245
|
|
Trend Review of Traditional Chinese Medicine Studies on Pharmacopuncture Treatment for Post-Stroke Depression
|
|
Lee Yeo-Gyeong
Khang Hyun-Jin Song Geum-Ju Oh Ji-Yeon Kim Sang-Beom Kim Jong-Min Park Se-Jin
|
|
Abstract
|
|
|
Objectives: To provide clinical evidence of pharmacopuncture treatment for post-stroke depression by reviewing randomized controlled trials on Traditional Chinese medicine pharmacopuncture for post-stroke depression.
Methods: Randomized controlled trials on pharmacopuncture treatment for post-stroke depression were searched from the China National Knowledge Infrastructure (CNKI). Literature searches of English and Chinese databases were performed. Selected literature was assessed with the Jadad scale.
Results: Twelve papers were selected from 20 studies. The following results were obtained: 1) Pharmacopuncture was used for post-stroke depression; 2) Dengzhan-Xixin was the most used injection medicine for post-stroke depression; 3) BaiHui (GV20) was the most used in pharmacopuncture treatment; 4) Based on the Hamilton Depression Rating Scale (HAMD), it was confirmed that all studies using pharmacopunture had significant efficacy.
Conclusions: For the treatment of post-stroke depression, Dengzhans-Xixin was commonly used as an injectable medication. Additional research studies on pharmacopuncture including its practical use are needed.
|
|
KEYWORD
|
|
Post-stroke depression, Traditional Chinese medicine, Pharmacopuncture, Randomized controlled trial, Review
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|